235. Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer

Reisinger, Kostan W.; Derikx, Joep P. M.; Vugt, J. van; Meyenfeldt, M. Von; Damink, Steven W. M. Olde; Poeze, Martijn; Hulsewé, Karel W. E.; Stoot, J.

doi:10.1016/j.ejso.2014.08.229

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is an association between sarcopenia with mortality, OS, recurrence-free survival, and postoperative complications. In this review, we found 13 studies 8 14 23 32 34 65 85 126 130 132 136 141 142 that reported on pancreatic and biliary malignancies and 31 studies 13 20 26 33 37 40 42 48 51 58 59 62 72 73 76 77 81 83 91 98 102 104 106 108 114 117 122 124 127 140 143 that reported on gastrointestinal and colorectal malignancies ( Tables 7 and 8 ).…”

Section: Introductionmentioning

confidence: 98%

“…After filtering out duplicates and screening titles and abstracts, 136 studies met the inclusion criteria. 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Radiological Assessment of Sarcopenia and Its Clinical Impact in Patients with Hepatobiliary, Pancreatic, and Gastrointestinal Diseases: A Comprehensive Review

Farook

Soni

Shantagiri

et al. 2023

Journal of Gastrointestinal and Abdominal Radiology

View full text Add to dashboard Cite

Sarcopenia is defined as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life, and death. The diagnosis of sarcopenia is based on documentation of two of the three criteria: low muscle mass, low muscle strength, and low physical performance. Imaging-based assessment of muscle mass is preferred in both clinical and research settings. Anthropometry for the evaluation of muscle mass is prone to errors and is not recommended in the clinical setting.There is a lack of literature on the radiological assessment of sarcopenia and its association with prognosis in hepatobiliary, pancreatic, and gastrointestinal diseases. Thus, we aim to provide a review of studies that utilized radiological methods to assess sarcopenia and evaluate its impact on outcomes in patients with these diseases.

show abstract